HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[A current view on dopamine receptor agonists in the treatment of Parkinson's disease].

Abstract
Dopamine receptor agonists (DRA) is a widely used group of antiparkinsonian drugs. The article presents short results: related to the mechanism of the stimulation of different types of dopamine receptors. The advantages of this group of drugs compared to levodopa medications as well as the studies of DRA in vitro and in vivo are described. Multiple studies demonstrate an important role of DRA in the treatment of Parkinson's disease (PD): a good control of motor symptoms, the possibility of monotherapy in the early stages of disease, the reduced risk of motor complications compared to start therapy with levodopa and decrease in the duration of "OFF-period" and UPDRS scores as well as the possibility to reduce the dose of levodopa in case of combined treatment with levodopa containing preparations. Pramipexole has demonstrated the efficacy in the treatment of persistent tremor and depression in double-blind placebo-controlled trials. A significant improvement of quality of life index has been shown in PD patients treated with these drugs. Side-effects often limited the use of DRA in clinical practice. The data on the dose equivalence of different DRA are recommended to use if it is necessary to switch from one DRA to another.
AuthorsN V Titova
JournalZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov (Zh Nevrol Psikhiatr Im S S Korsakova) Vol. 115 Issue 9 Pg. 76-83 ( 2015) ISSN: 1997-7298 [Print] Russia (Federation)
PMID26525820 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Antiparkinson Agents
  • Benzothiazoles
  • Dopamine Agonists
  • Levodopa
  • pramipexole
Topics
  • Antiparkinson Agents (adverse effects, therapeutic use)
  • Benzothiazoles (adverse effects, therapeutic use)
  • Controlled Clinical Trials as Topic
  • Dopamine Agonists (adverse effects, therapeutic use)
  • Double-Blind Method
  • Humans
  • Levodopa (adverse effects, therapeutic use)
  • Parkinson Disease (drug therapy)
  • Quality of Life
  • Tremor (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: